David Szekeres

COO

Other Board Member Chairman Board Member

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year	Company	Role	Salary	Bonus	Stock awards	Option awards	Incentive	Other	Total
2022	Heron Therapeutics, Inc. /De/ (HRTX)	Executive Vice President, Chief Commercial Officer	$533,013	—	$441,456	$235,482	$199,880	$19,400	$1,429,231
2021	Heron Therapeutics, Inc. /De/ (HRTX)	Executive Vice President, Chief Commercial Officer	$494,400	—	$583,626	$535,147	$197,760	$18,498	$1,829,431
2020	Heron Therapeutics, Inc. /De/ (HRTX)	Executive Vice President, Chief Operating Officer	$476,910	—	$314,400	$1,500,673	$161,664	$8,550	$2,462,197

Executive changes

Resigned Executive Vice President, Chief Operating Officer at Heron Therapeutics, Inc. /De/ (HRTX)
2023-07-20
Appointed Chairperson of the Board at GRI Bio, Inc. (GRI)
2023-04-21
Appointed Director at GRI Bio, Inc. (GRI)
2023-04-21

Earnings-call appearances

Heron Therapeutics, Inc. /De/ Q1 FY2023 Earnings Call
Heron Therapeutics, Inc. /De/ (HRTX)

2023-05-11
Heron Therapeutics, Inc. /De/ Q4 FY2022 Earnings Call
Heron Therapeutics, Inc. /De/ (HRTX)

2023-01-09
Heron Therapeutics, Inc. /De/ Q3 FY2022 Earnings Call
Heron Therapeutics, Inc. /De/ (HRTX)

2022-11-08
Heron Therapeutics, Inc. /De/ Q2 FY2022 Earnings Call
Heron Therapeutics, Inc. /De/ (HRTX)

2022-08-09
Heron Therapeutics, Inc. /De/ Q1 FY2022 Earnings Call
Heron Therapeutics, Inc. /De/ (HRTX)

2022-05-09
Heron Therapeutics, Inc. /De/ Q4 FY2021 Earnings Call
Heron Therapeutics, Inc. /De/ (HRTX)

2022-02-28
Heron Therapeutics, Inc. /De/ Q3 FY2021 Earnings Call
Heron Therapeutics, Inc. /De/ (HRTX)

2021-11-03